Cardiac Muscle Hypertrophy and Cellular Adaptation

Definition and Principles of Hypertrophy

  • Core Definition: Hypertrophy is a compensatory increase in the size of individual cells occurring in response to mechanical load or stress, which ultimately results in an increased size of the affected organ.
  • Triggers: Common triggers initiating hypertrophy include:
    • Repetitive stretching
    • Chronic pressure
    • Volume overload
  • Susceptible Cell and Organ Types:
    • The cells of the heart and kidneys are particularly prone to cellular enlargement.
    • Hypertrophy occurs as an adaptive response within striated muscle cells of both the heart and skeletal muscles.
  • Clinical Presentation: Hypertrophy presents clinically as muscle enlargement.

Cardiac Muscle Hypertrophy and Protein Synthesis

  • Left Ventricular Hypertrophy (LVH): Cardiac muscle hypertrophy typically manifests as left ventricular hypertrophy.
  • Molecular Mechanism: An increased synthesis of cardiac muscle proteins follows the mechanical load or stress, enabling cardiac muscle fibers to perform more work (Fig2.3).
  • Classification: Hypertrophy is broadly categorized into two distinct types:
    • Physiologic hypertrophy
    • Pathologic hypertrophy

Physiologic Hypertrophy

  • Etiology and Stimuli: Physiologic hypertrophy results from:
    • Increased mechanical demand
    • Stimulation by hormones
    • Stimulation by growth factors
  • Representative Example: Enlargement secondary to regular aerobic exercise, commonly referred to as a "runner's heart."
  • Structural and Functional Characteristics:
    • No underlying pathology is present.
    • Normal tissue structure and function are fully preserved.
    • The myocardial matrix is preserved without structural degeneration.

Pathologic Hypertrophy

  • Etiology and Stimuli: Pathologic hypertrophy results from chronic hemodynamic overload. Common primary etiologies include:
    • Hypertension (LVH occurring secondary to hypertension represents pathologic hypertrophy)
    • Heart valve dysfunction
  • Clinical Course and Progression:
    • Initial Adaptation: Presents as cardiac enlargement with dilated ventricles; however, this adaptive phase is short-lived.
    • Decompensation: Prolonged cardiac hypertrophy progressively leads to contractile dysfunction.
    • Terminal Outcome: Ultimately progresses to heart failure.
  • Histopathological and Functional Alterations: In contrast to physiologic hypertrophy:
    • Associated with significantly increased interstitial fibrosis.
    • Involves cell death.
    • Leads to abnormal cardiac function (FIG2.3).

Compensatory Renal Hypertrophy

  • Trigger: Occurs following a unilateral nephrectomy (surgical removal of one kidney).
  • Effect: Compensatory hypertrophy takes place in the remaining single kidney.
  • Clinical Outcome: Preserves overall renal structure and function.